| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |